Drug profile · INN
cephalothin sodium
KEFLIN
cephalothin sodium (KEFLIN) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — cephalothin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
cephalothin sodium (KEFLIN) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cephalothin sodium?
cephalothin sodium (KEFLIN) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cephalothin sodium?
KEFLIN is a marketed brand name for cephalothin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cephalothin sodium?
cephalothin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.